+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Wound Care: Tissue-Engineered Skin Replacements and Active Wound Repair Modulators

  • ID: 4775292
  • Report
  • 53 pages
  • Datamonitor Healthcare
1 of 2
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the US, 5EU, Japan, and RoW markets for tissue-engineered skin replacements (epidermal, dermal, and multilayer equivalents, and amniotic tissue grafts) and active wound repair modulators (growth factors, gene therapy agents, and stem cells).

Key Questions Answered
  • What are the key drivers and limiters to the global wound care products market?
  • Which competitors are leading the market and introducing new technology?
  • How are technological advancements impacting market growth?
  • Which areas of the wound care products market are experiencing dynamic growth?
  • How are mergers and acquisitions affecting the markets shares of leading competitors?
Would Care Highlights
  • The combined global market for tissue-engineered skin replacements and active wound repair modulators totaled more than $1bn in 2017, and is expected to climb at a rate of 6.0% over the next half-decade.
  • The tissue-engineered skin replacements segment accounts for nearly 90% of sales, with the 5EU markets, Japan, and the RoW markets combined accounting for the remaining 10% of sales.
  • The US accounts for nearly 92% of global sales in this market, due to factors including slower adoption of skin replacements in international markets as a result of cultural aversion to the use of cadaveric tissue, concerns regarding disease transmission, and limited reimbursement.
Note: Product cover images may vary from those shown
2 of 2
Executive Summary

Tissue-Engineered Skin Replacements
Autologous and tissue-engineered skin replacements
Epidermal equivalent products
Dermal equivalent products
Multilayer equivalent products
Amniotic tissue grafts
Market forecast
Competitive analysis
Exhibit 1-1: Tissue-engineered skin replacements, market forecast, 2017-22
Exhibit 1-2: Tissue-engineered skin replacements market, share by supplier, 2017

Active Wound Repair Modulators
Growth factors
Growth factor classification
Competitors and products
Market forecast
Gene therapy agents
Stem cells
Types of stem cells
The role of stem cells in wound healing
Other active wound repair modulators and pharmaceuticals
Antibiotics and anti-infectives
Matrix metalloproteinase enzyme inhibitors
Neuropeptides in diabetic wounds
Other products
Exhibit 2-1: Selected growth factors under development for wound healing applications
Exhibit 2-2: The angiogenesis process
Exhibit 2-3: Growth factors, market forecast ($m), 2017-22

Appendix: Company Listing
Note: Product cover images may vary from those shown
3 of 2